Login to Your Account

Unanswered questions linger on co-development of companion diagnostics

By Mark McCarty
Regulatory Editor

Friday, July 29, 2016

The FDA has published the long-awaited draft guidance for co-development of a therapeutic drug and a companion diagnostic, but the agency has scheduled an Aug. 18 webinar to address questions associated with the draft.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription